查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600798

表觀遺傳學市場：按產品、技術、工藝、應用和最終用戶分類 - 全球預測 2025-2030

Epigenetics Market by Product, Technique, Methods, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年表觀遺傳學市場價值為37.1億美元，預計到2024年將達到41億美元，複合年成長率為10.82%，到2030年將達到76.3億美元。

表觀遺傳學是一個快速發展的領域，涉及基因功能的遺傳變化的研究，不涉及DNA序列的變化，以了解複雜的生物過程，例如發育、疾病表達和對環境因素的反應，在上述過程中發揮著重要作用。表觀遺傳學的需求在於闡明癌症、神經系統疾病和自體免疫疾病等各種疾病的潛在機制，從而實現標靶治療方法和個人化醫療。其應用範圍廣泛，包括藥物發現、生物標記物開發、農業和環境研究，最終用途主要在醫療保健、製藥和生物技術行業。市場成長是由次世代定序和 CRISPR 等技術進步、慢性病盛行率增加以及研發投資增加所推動的。然而，與表觀表觀基因研究相關的高成本、倫理問題和資料解釋的複雜性構成了重大挑戰。為了利用潛在的機會，相關人員應專注於降低定序成本和增強資料分析工具。學術機構和行業相關人員之間的合作可以促進新表觀遺傳標靶的識別和相應治療方法的開發方面的創新。雖然北美和歐洲等地區目前憑藉成熟的醫療保健系統引領市場，但亞太地區的新興市場由於基礎設施的改善和醫療保健支出的增加而提供了利潤豐厚的機會。監管障礙和有限的報銷框架等限制可能會阻礙市場的快速擴張。在改進診斷工具、開發表觀遺傳生物標記以及可以修改表觀遺傳標記的新治療方法還有創新的空間。為了保持競爭力，公司應該專注於策略夥伴關係、客製化產品以及利用人工智慧進行資料分析。總體而言，表觀遺傳學市場的動態性質需要靈活的策略和持續的創新來克服挑戰並利用巨大的成長潛力。

主要市場統計
基準年[2023] 37.1億美元
預測年份 [2024] 41億美元
預測年份 [2030] 76.3億美元
複合年成長率（%） 10.82%

市場動態：揭示快速發展的表觀遺傳學市場的關鍵市場洞察

表觀遺傳學市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球慢性病和遺傳疾病的盛行率顯著增加
    • 政府在藥物發現和開發方面的積極措施和投資
    • 對個人化醫療的偏好日益增加
  • 市場限制因素
    • 開發表觀遺傳學技術成本高昂
  • 市場機會
    • 持續進行研究和開發活動以推進表觀遺傳學
    • 將表觀遺傳學的應用擴展到非癌症領域
  • 市場挑戰
    • 表觀遺傳學認知不足，應用範圍狹窄

波特的五力策略工具駕馭表觀遺傳學市場

波特的五力框架是了解表觀遺傳學市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解表觀遺傳學市場的外部影響

外部宏觀環境因素在塑造表觀遺傳學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解表觀遺傳學市場的競爭格局

表觀遺傳學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣表觀遺傳學市場供應商績效評估

FPNV定位矩陣是評估表觀遺傳學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性病和遺傳疾病的盛行率正在顯著增加。
      • 政府在藥物發現和開發方面的有利措施和投資
      • 個性化醫療的成長趨勢
    • 抑制因素
      • 表觀遺傳學技術開發成本高
    • 機會
      • 持續進行表觀遺傳學的研究與發展活動
      • 將表觀遺傳學的應用擴展到非腫瘤學領域
    • 任務
      • 表觀遺傳學缺乏認知且應用有限
  • 市場區隔分析
    • 產品：表觀遺傳學研究試劑和套件的使用增加
    • 技術：擴大次世代定序在全基因組甲基化分析的應用
    • 方法：增加 X 染色體惰性中 DNA 甲基化的利用率
    • 應用：增加表觀遺傳學工具在腫瘤學的應用
    • 最終用戶：學術和研究機構對錶觀遺傳學工具的需求不斷成長
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章表觀遺傳學市場：依產品

  • 酵素
    • DNA修飾酶
    • 蛋白質修飾酶
  • 樂器及配件
  • 試劑和套件
    • 5-hmC 和 5-mC 分析套件
    • 抗體
    • 亞硫酸氫鹽轉換套件
    • ChiP-seq套件
    • 組蛋白
    • 全基因組擴增試劑套件
  • 服務
  • 軟體

第7章表觀遺傳學市場：依技術分類

  • 質譜分析
  • 次世代定序
  • 聚合酵素鏈鎖反應與定量聚合酵素鏈鎖反應
  • 超音波

第 8 章表觀遺傳學市場（依方法）

  • DNA甲基化
  • 組蛋白修飾

第9章表觀遺傳學市場：依應用分類

  • 心血管疾病
  • 發育生物學
  • 免疫學
  • 代謝性疾病
  • 腫瘤學

第 10 章表觀遺傳學市場：依最終使用者分類

  • 學術研究所
  • 合約調查機構
  • 製藥和生物技術公司

第11章美洲表觀遺傳學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太表觀遺傳學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的表觀遺傳學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Zenith 和 Sencora 合作加速 ZEN-3694 項目
    • FOXO 與 DataRobot 合作進行以人工智慧為基礎的表觀遺傳生物標記研究
    • Zymo Investigations 和 Opentrons 合作實現新型無細胞 DNA 分離化學的自動化
    • MSU 生物化學家接受NIH 280 萬美元津貼，用於研究泛自閉症障礙的表觀遺傳學
    • 安捷倫宣布收​​購用於癌症研究的高性能 NGS靶向序列捕獲工作流程開發商 Avida Biomed
    • Astra Zeneca推進產品線，在 AACR 上強調免疫腫瘤學、ADC、細胞治療和表觀遺傳學的進展
    • Biomodal 發布遺傳學和表觀遺傳學解決方案
    • Chroma Medicine 專注於表觀遺傳編輯
    • 易卜生收購 Epizyme 以擴大腫瘤產品組合
    • Zenith Epi Genetics 宣布開始由美國國家癌症研究所 (NCI) 贊助的多項腫瘤學臨床試驗

公司名單

  • Diagenode SA by Hologic, Inc.
  • STORM Therapeutics LTD
  • Qiagen NV
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Active Motif, Inc.
  • Merck KGaA
  • Novogene Co, Ltd.
  • GenomeScan
  • Thermo Fisher Scientific Inc.
  • Abnova Corporation
  • New England Biolabs, Inc.
  • Epigenic Therapeutics
  • Ipsen
  • Twist Bioscience Corporation
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca PLC
  • GenScript Biotech Corporation
  • Exact Sciences Corporation
  • FOXO Technologies Inc.
  • Watchmaker Genomics, Inc.
  • Chroma Medicine, Inc.
  • Cambridge Epigenetix Ltd.
  • Bristol-Myers Squibb Company
  • EpiCypher, Inc.
  • Omega Therapeutics, Inc.
  • Promega Corporation
  • Bioneer Corporation
  • PerkinElmer, Inc.
  • Gilead Sciences, Inc.
  • Eurofins Scientific SE
  • ProteoGenix SAS
  • Abcam PLC
  • BioCat GmbH by AddLife AB
  • Creative Diagnostics
  • EpiGentek Group Inc.
  • Lonza Group Ltd.
  • Zenith Epigenetics Ltd.
  • Agilent Technologies, Inc.
  • BPS Bioscience, Inc.
  • Fios Genomics Ltd.
  • Creative Biogene
  • Sound Agriculture Company
  • Takara Holdings Inc.
  • Illumina, Inc.
  • Elysium Health, Inc.
  • Pacific Biosciences of California, Inc
  • Cusabio Technology LLC
  • Zymo Research Corporation
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • MorphoSys AG
Product Code: MRR-0D217D5ADE3D

The Epigenetics Market was valued at USD 3.71 billion in 2023, expected to reach USD 4.10 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 7.63 billion by 2030.

Epigenetics, a burgeoning field involving the study of heritable changes in gene function that do not involve alterations in the DNA sequence, plays a crucial role in understanding complex biological processes such as development, disease manifestation, and response to environmental factors. The necessity of epigenetics lies in its potential to unravel mechanisms underlying various diseases, including cancer, neurological disorders, and autoimmune diseases, thus enabling targeted therapeutic approaches and personalized medicine. Its applications span across drug discovery, biomarkers development, agriculture, and environmental studies, with end-use predominantly in healthcare, pharmaceutical, and biotech industries. Market growth is driven by advancements in technology such as next-generation sequencing and CRISPR, increasing prevalence of chronic diseases, and growing investment in R&D. However, high costs associated with epigenomic research, ethical concerns, and complexity in data interpretation pose significant challenges. To capitalize on potential opportunities, stakeholders should focus on reducing sequencing costs and enhancing data analysis tools. Collaborations between academic institutions and industry players could foster innovation in identifying novel epigenetic targets and developing corresponding therapies. Currently, regions like North America and Europe lead the market due to established healthcare systems, but emerging markets in Asia-Pacific present lucrative opportunities owing to improving infrastructure and increasing healthcare expenditure. Limitations such as regulatory hurdles and limited reimbursement frameworks may hinder rapid market expansion. The scope for innovation lies in improved diagnostic tools, development of epigenetic biomarkers, and novel therapies that can modify epigenetic marks. Businesses should focus on strategic partnerships, tailored product offerings, and leveraging artificial intelligence for data analysis to stay competitive. Overall, the dynamic nature of the epigenetics market demands agile strategies and sustained innovation to navigate the challenges and capitalize on the vast potential for growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.71 billion
Estimated Year [2024] USD 4.10 billion
Forecast Year [2030] USD 7.63 billion
CAGR (%) 10.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Epigenetics Market

The Epigenetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant growth in the prevalence of chronic and genetic disorders worldwide
    • Favorable governmental initiatives and investments in drug discovery and development
    • Growing inclination toward personalized medicines
  • Market Restraints
    • High cost of development of epigenetics technologies
  • Market Opportunities
    • Ongoing research and development activities for the advancement of epigenetics
    • Expanding the application of epigenetics in non-oncology fields
  • Market Challenges
    • Lack of awareness and limited application of epigenetics

Porter's Five Forces: A Strategic Tool for Navigating the Epigenetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Epigenetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Epigenetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Epigenetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Epigenetics Market

A detailed market share analysis in the Epigenetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Epigenetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Epigenetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Diagenode S.A. by Hologic, Inc., STORM Therapeutics LTD, Qiagen N.V., Integrated DNA Technologies, Inc. by Danaher Corporation, Active Motif, Inc., Merck KGaA, Novogene Co, Ltd., GenomeScan, Thermo Fisher Scientific Inc., Abnova Corporation, New England Biolabs, Inc., Epigenic Therapeutics, Ipsen, Twist Bioscience Corporation, F. Hoffmann-La Roche Ltd., AstraZeneca PLC, GenScript Biotech Corporation, Exact Sciences Corporation, FOXO Technologies Inc., Watchmaker Genomics, Inc., Chroma Medicine, Inc., Cambridge Epigenetix Ltd., Bristol-Myers Squibb Company, EpiCypher, Inc., Omega Therapeutics, Inc., Promega Corporation, Bioneer Corporation, PerkinElmer, Inc., Gilead Sciences, Inc., Eurofins Scientific SE, ProteoGenix SAS, Abcam PLC, BioCat GmbH by AddLife AB, Creative Diagnostics, EpiGentek Group Inc., Lonza Group Ltd., Zenith Epigenetics Ltd., Agilent Technologies, Inc., BPS Bioscience, Inc., Fios Genomics Ltd., Creative Biogene, Sound Agriculture Company, Takara Holdings Inc., Illumina, Inc., Elysium Health, Inc., Pacific Biosciences of California, Inc, Cusabio Technology LLC, Zymo Research Corporation, Bayer AG, Bio-Rad Laboratories, Inc., and MorphoSys AG.

Market Segmentation & Coverage

This research report categorizes the Epigenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Enzymes, Instruments & Accessories, Reagents & Kits, Service, and Software. The Enzymes is further studied across DNA-Modifying Enzymes and Protein-Modifying Enzymes. The Reagents & Kits is further studied across 5-hmC & 5-mC Analysis Kit, Antibodies, Bisulfite Conversion Kits, ChiP-seq Kits, Histones, and Whole Genome Amplification Kits.
  • Based on Technique, market is studied across Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction, and Sonication.
  • Based on Methods, market is studied across DNA Methylation and Histone Modifications.
  • Based on Application, market is studied across Cardiovascular Diseases, Developmental Biology, Immunology, Metabolic Diseases, and Oncology.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant growth in the prevalence of chronic and genetic disorders worldwide
      • 5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
      • 5.1.1.3. Growing inclination toward personalized medicines
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of epigenetics technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities for the advancement of epigenetics
      • 5.1.3.2. Expanding the application of epigenetics in non-oncology fields
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and limited application of epigenetics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing usage of reagents & kits for epigenetic research
    • 5.2.2. Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
    • 5.2.3. Methods: Rising utilization of DNA methylation for X-chromosome inactivation
    • 5.2.4. Application: Increasing application of epigenetic tools in oncology
    • 5.2.5. End-User: Growing need for epigenetic tools from academic & research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Epigenetics Market, by Product

  • 6.1. Introduction
  • 6.2. Enzymes
    • 6.2.1. DNA-Modifying Enzymes
    • 6.2.2. Protein-Modifying Enzymes
  • 6.3. Instruments & Accessories
  • 6.4. Reagents & Kits
    • 6.4.1. 5-hmC & 5-mC Analysis Kit
    • 6.4.2. Antibodies
    • 6.4.3. Bisulfite Conversion Kits
    • 6.4.4. ChiP-seq Kits
    • 6.4.5. Histones
    • 6.4.6. Whole Genome Amplification Kits
  • 6.5. Service
  • 6.6. Software

7. Epigenetics Market, by Technique

  • 7.1. Introduction
  • 7.2. Mass Spectrometry
  • 7.3. Next-Generation Sequencing
  • 7.4. Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
  • 7.5. Sonication

8. Epigenetics Market, by Methods

  • 8.1. Introduction
  • 8.2. DNA Methylation
  • 8.3. Histone Modifications

9. Epigenetics Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Developmental Biology
  • 9.4. Immunology
  • 9.5. Metabolic Diseases
  • 9.6. Oncology

10. Epigenetics Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Epigenetics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Epigenetics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Epigenetics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Zenith and Cencora Partner to Expedite ZEN-3694 Programme
    • 14.3.2. FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research
    • 14.3.3. Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
    • 14.3.4. MSU biochemist Receives USD 2.8 million NIH Grant For Epigenetic Research on Autism Spectrum Disorder
    • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
    • 14.3.6. AstraZeneca Advances its Pipeline and Highlights Progress in Immuno-Oncology, ADCs, Cell Therapy and Epigenetics At AACR
    • 14.3.7. Biomodal Releases Genetics And Epigenetics Solution
    • 14.3.8. Chroma Medicine Raises Stakes in Epigenetic Editing
    • 14.3.9. Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
    • 14.3.10. Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials

Companies Mentioned

  • 1. Diagenode S.A. by Hologic, Inc.
  • 2. STORM Therapeutics LTD
  • 3. Qiagen N.V.
  • 4. Integrated DNA Technologies, Inc. by Danaher Corporation
  • 5. Active Motif, Inc.
  • 6. Merck KGaA
  • 7. Novogene Co, Ltd.
  • 8. GenomeScan
  • 9. Thermo Fisher Scientific Inc.
  • 10. Abnova Corporation
  • 11. New England Biolabs, Inc.
  • 12. Epigenic Therapeutics
  • 13. Ipsen
  • 14. Twist Bioscience Corporation
  • 15. F. Hoffmann-La Roche Ltd.
  • 16. AstraZeneca PLC
  • 17. GenScript Biotech Corporation
  • 18. Exact Sciences Corporation
  • 19. FOXO Technologies Inc.
  • 20. Watchmaker Genomics, Inc.
  • 21. Chroma Medicine, Inc.
  • 22. Cambridge Epigenetix Ltd.
  • 23. Bristol-Myers Squibb Company
  • 24. EpiCypher, Inc.
  • 25. Omega Therapeutics, Inc.
  • 26. Promega Corporation
  • 27. Bioneer Corporation
  • 28. PerkinElmer, Inc.
  • 29. Gilead Sciences, Inc.
  • 30. Eurofins Scientific SE
  • 31. ProteoGenix SAS
  • 32. Abcam PLC
  • 33. BioCat GmbH by AddLife AB
  • 34. Creative Diagnostics
  • 35. EpiGentek Group Inc.
  • 36. Lonza Group Ltd.
  • 37. Zenith Epigenetics Ltd.
  • 38. Agilent Technologies, Inc.
  • 39. BPS Bioscience, Inc.
  • 40. Fios Genomics Ltd.
  • 41. Creative Biogene
  • 42. Sound Agriculture Company
  • 43. Takara Holdings Inc.
  • 44. Illumina, Inc.
  • 45. Elysium Health, Inc.
  • 46. Pacific Biosciences of California, Inc
  • 47. Cusabio Technology LLC
  • 48. Zymo Research Corporation
  • 49. Bayer AG
  • 50. Bio-Rad Laboratories, Inc.
  • 51. MorphoSys AG

LIST OF FIGURES

  • FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
  • FIGURE 2. EPIGENETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPIGENETICS MARKET DYNAMICS
  • TABLE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 332. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 333. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023